Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10M Buy
119,478
+905
+0.8% +$68.2K 0.05% 324
2025
Q4
$7.95M Buy
118,573
+6,651
+6% +$430K 0.04% 364
2025
Q3
$7.56M Buy
111,922
+10,944
+11% +$793K 0.05% 327
2025
Q2
$7.5M Buy
100,978
+10,409
+11% +$693K 0.06% 281
2025
Q1
$5.53M Sell
90,569
-5,127
-5% -$317K 0.06% 279
2024
Q4
$5.36M Buy
95,696
+33,910
+55% +$2.01M 0.06% 265
2024
Q3
$3.63M Buy
61,786
+45,454
+278% +$2.48M 0.07% 253
2024
Q2
$876K Buy
16,332
+11,503
+238% +$633K 0.04% 387
2024
Q1
$278K Buy
4,829
+200
+4% +$10.3K 0.04% 386
2023
Q4
$222K Buy
4,629
+606
+15% +$28.9K 0.05% 255
2023
Q3
$206K Buy
4,023
+121
+3% +$6.41K 0.1% 163
2023
Q2
$224K Buy
3,902
+111
+3% +$6.48K 0.1% 157
2023
Q1
$229K Hold
3,791
0.11% 148
2022
Q4
$223K Hold
3,791
0.11% 157
2022
Q3
$217K Hold
3,791
0.13% 152
2022
Q2
$205K Hold
3,791
0.12% 166
2022
Q1
$218K Buy
+3,791
New +$194K 0.12% 174

Other funds holding CTVA

&Partners's CTVA Position: Q1 2026 in Review

&Partners increased its Corteva (CTVA) stake by 0.76% in Q1 2026, buying an estimated $68.2K and bringing the position to 119,478 shares worth $10M. The position accounts for 0.05% of the portfolio, ranked #324.

&Partners first reported a position in CTVA in Q1 2022 and has held it in 17 quarters since. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • &Partners held 119,478 shares of Corteva worth $10M as of Q1 2026.
  • &Partners bought 905 Corteva shares in Q1 2026, an estimated $68.2K.
  • Corteva made up 0.05% of &Partners's portfolio in Q1 2026, its #324 holding.
  • &Partners first reported a position in Corteva in Q1 2022 and has held it in 17 quarters since.
  • 1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.